OBJECT: The purpose of this review is to describe the incidence, causes, management, and outcome of aneurysmal hemorrhage that occurred in patients during endovascular treatment with the Guglielmi detachable coil (GDC) system. METHODS: At the authors' institution between September 1991 and August 1995, more than 200 patients were treated using GDCs for intracranial aneurysms. The first 200 patients treated in this fashion were reviewed and all who experienced new subarachnoid hemorrhage (SAH) during the procedure were identified. Angiographic studies were also reviewed and patients were contacted for longer-term follow up when possible. Four patients who experienced intraprocedural SAH were identified. The causes of hemorrhage were believed to be perforation of the aneurysm by the guidewire in one patient, perforation by the microcatheter in a second, and perforation by the delivery wire in a third. The fourth patient had a hemorrhage during injection of contrast material for control angiographic studies after placement of the final coil. One patient died, but the other three experienced no neurological symptoms or recovered without acquiring additional deficits. Overall a procedural hemorrhage rate of 2% was seen, with permanent morbidity and mortality rates of 0% and 0.5%, respectively. CONCLUSIONS: Although SAH during endovascular treatment of intracranial aneurysms remains a significant risk, its incidence is low and a majority of patients can survive without serious sequelae.
OBJECT: The purpose of this review is to describe the incidence, causes, management, and outcome of aneurysmal hemorrhage that occurred in patients during endovascular treatment with the Guglielmi detachable coil (GDC) system. METHODS: At the authors' institution between September 1991 and August 1995, more than 200 patients were treated using GDCs for intracranial aneurysms. The first 200 patients treated in this fashion were reviewed and all who experienced new subarachnoid hemorrhage (SAH) during the procedure were identified. Angiographic studies were also reviewed and patients were contacted for longer-term follow up when possible. Four patients who experienced intraprocedural SAH were identified. The causes of hemorrhage were believed to be perforation of the aneurysm by the guidewire in one patient, perforation by the microcatheter in a second, and perforation by the delivery wire in a third. The fourth patient had a hemorrhage during injection of contrast material for control angiographic studies after placement of the final coil. One patient died, but the other three experienced no neurological symptoms or recovered without acquiring additional deficits. Overall a procedural hemorrhage rate of 2% was seen, with permanent morbidity and mortality rates of 0% and 0.5%, respectively. CONCLUSIONS: Although SAH during endovascular treatment of intracranial aneurysms remains a significant risk, its incidence is low and a majority of patients can survive without serious sequelae.
Authors: John G Short; William F Marx; Giuseppe Lanzino; Dilantha B Ellegala; Neil F Kassell Journal: AJNR Am J Neuroradiol Date: 2002-04 Impact factor: 3.825
Authors: Ke Zhang; Axel Joachim Krafft; Reiner Umathum; Florian Maier; Wolfhard Semmler; Michael Bock Journal: MAGMA Date: 2010-05-21 Impact factor: 2.310
Authors: Fabio Settecase; Marshall S Sussman; Mark W Wilson; Steven Hetts; Ronald L Arenson; Vincent Malba; Anthony F Bernhardt; Walter Kucharczyk; Timothy P L Roberts Journal: Med Phys Date: 2007-08 Impact factor: 4.071
Authors: Steven W Hetts; Maythem Saeed; Alastair Martin; Prasheel Lillaney; Aaron Losey; Erin Jeannie Yee; Ryan Sincic; Loi Do; Lee Evans; Vincent Malba; Anthony F Bernhardt; Mark W Wilson; Anand Patel; Ronald L Arenson; Curtis Caton; Daniel L Cooke Journal: J Vis Exp Date: 2013-04-04 Impact factor: 1.355